The Misuse of Drugs Act 1971 (Amendment) Order 2021
At the Court at Windsor Castle, the 21st day of July 2021
Present,
The Queen’s Most Excellent Majesty in Council
Accordingly, Her Majesty, in exercise of the powers conferred on Her by section 2(2) of that Act, is pleased, by and with the advice of Her Privy Council, to order as follows:
Citation, commencement and extent1.
(1)
This Order may be cited as the Misuse of Drugs Act 1971 (Amendment) Order 2021 and comes into force twenty-eight days after the day on which it is made.
(2)
This Order extends to England and Wales, Scotland and Northern Ireland.
Amendment to the Misuse of Drugs Act 19712.
(1)
The following amendments are made to Part 3 of Schedule 2 to the Misuse of Drugs Act 1971 (which specifies the drugs which are subject to control under that Act as Class C drugs).
(2)
(a)
after “Fenproporex.” insert “Flualprazolam (8-chloro-6-(2-fluorophenyl)-1-methyl-4H-[1,2,4]triazolo[4,3-a][1,4]benzodiazepine).”;
(b)
after “Flunitrazepam.” insert “Flunitrazolam (6-(2-fluorophenyl)-1-methyl-8-nitro-4H-[1,2,4]triazolo[4,3-a][1,4]benzodiazepine).”;
(c)
after “Nordazepam.” insert “Norfludiazepam (7-chloro-5-(2-fluorophenyl)-1,3-dihydro-2H-1,4-benzodiazepin-2-one).”.
This Order brings certain drugs under the control of the Misuse of Drugs Act 1971 (c. 38). Article 2(2) of this Order brings three benzodiazepines, being the compounds known as flualprazolam, flunitrazolam and norfludiazepam, under control as Class C drugs under that Act.
A full impact assessment has not been produced for this instrument as no, or no significant, impact on the private, voluntary or public sectors is foreseen.